Jabbour, Elia: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Practical advice for determining the role of BCR-ABL mutations in guiding tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Elias Jabbour, Susan Branford, Giuseppe Saglio, Dan Jones, Jorge E. Cortes, Hagop M. Kantarjian

Journal:

Year:

2011

Language:

english

File:

PDF, 288 KB

english, 2011

52

Prognostic impact of deletions of derivative chromosome 9 in patients with chronic myelogenous leukemia treated with nilotinib or dasatinib

Alfonso Quintás-Cardama, Hagop Kantarjian, Jianqin Shan, Elias Jabbour, Lynne V. Abruzzo, Srdan Verstovsek, Guillermo Garcia-Manero, Susan O'Brien, Jorge Cortes

Journal:

Year:

2011

Language:

english

File:

PDF, 230 KB

english, 2011

53

A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

Stefan Faderl, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Zeev Estrov, Varsha Gandhi, Anna L. Byrd, Monica Kwari, Jorge Cortes, Hagop M. Kantarjian

Journal:

Year:

2012

Language:

english

File:

PDF, 181 KB

english, 2012

54

Suboptimal responses in chronic myeloid leukemia : Implications and management strategies

Elias Jabbour, Giuseppe Saglio, Timothy P. Hughes, Hagop Kantarjian

Journal:

Year:

2012

Language:

english

File:

PDF, 840 KB

english, 2012

55

Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia

Abdul Rahman El Kinge, Hassan A. Hatoum, Rami A. Mahfouz, Zaher K. Otrock, Elias Jabbour, Hagop Kantarjian, Ali Bazarbachi

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 102 KB

english, 2009

56

Clinical experience with decitabine in North American patients with myelodysplastic syndrome

Karen W. L. Yee, Elias Jabbour, Hagop M. Kantarjian, Francis J. Giles

Journal:

Annals of Hematology

Year:

2005

Language:

english

File:

PDF, 127 KB

english, 2005

57

The clinical challenge of imatinib resistance in chronic myeloid leukemia: emerging strategies with new targeted agents

Elias Jabbour, Jorge Cortes, Francis Giles, Susan O’Brien, Hagop Kantarjian

Journal:

Targeted Oncology

Year:

2006

Language:

english

File:

PDF, 275 KB

english, 2006

58

Treatment selection after imatinib resistance in chronic myeloid leukemia

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Journal:

Targeted Oncology

Year:

2009

Language:

english

File:

PDF, 158 KB

english, 2009

59

New agents in myelodysplastic syndromes

Elias Jabbour, Francis J. Giles

Journal:

Current Hematologic Malignancy Reports

Year:

2006

Language:

english

File:

PDF, 146 KB

english, 2006

60

Novel therapies for relapsed acute lymphoblastic leukemia

Amber Fullmer, Susan O’Brien, Hagop Kantarjian, Elias Jabbour

Journal:

Current Hematologic Malignancy Reports

Year:

2009

Language:

english

File:

PDF, 314 KB

english, 2009

61

Rapid clonal shifts in response to kinase inhibitor therapy in chronic myelogenous leukemia are identified by quantitation mutation assays

C. Cameron Yin, Jorge Cortes, John Galbincea, Neelima Reddy, Megan Breeden, Elias Jabbour, Rajyalakshmi Luthra, Dan Jones

Journal:

Year:

2010

Language:

english

File:

PDF, 324 KB

english, 2010

62

Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse

Francis Giles, Srdan Verstovsek, Guillermo Garcia-Manero, Deborah Thomas, Farhad Ravandi, William Wierda, Alessandra Ferrajoli, Steve Kornblau, Elias Jabbour, Jianqin Shan, Susan O'Brien, Maher Albita

Journal:

British Journal of Haematology

Year:

2006

Language:

english

File:

PDF, 191 KB

english, 2006

63

Dasatinib

Kantarjian, Hagop, Jabbour, Elias, Grimley, Joanne, Kirkpatrick, Peter

Journal:

Nature Reviews Drug Discovery

Year:

2006

Language:

english

File:

PDF, 162 KB

english, 2006

64

Treatment options for chronic myeloid leukemia

Tanaka, Maria Florencia, Kantarjian, Hagop, Cortes, Jorge, Ohanian, Maro, Jabbour, Elias

Journal:

Expert Opinion on Pharmacotherapy

Year:

2012

Language:

english

File:

PDF, 292 KB

english, 2012

65

Tyrosine kinase inhibitors in acute and chronic leukemias

Ohanian, Maro, Cortes, Jorge, Kantarjian, Hagop, Jabbour, Elias

Journal:

Expert Opinion on Pharmacotherapy

Year:

2012

Language:

english

File:

PDF, 298 KB

english, 2012

66

Patient adherence to tyrosine kinase inhibitor therapy in chronic myeloid leukemia

Elias J. Jabbour, Hagop Kantarjian, Lina Eliasson, A. Megan Cornelison, David Marin

Journal:

American Journal of Hematology

Year:

2012

Language:

english

File:

PDF, 833 KB

english, 2012

67

Very long-term follow-up results of imatinib mesylate therapy in chronic phase chronic myeloid leukemia after failure of interferon alpha therapy

Hagop Kantarjian, Susan O'Brien, Guillermo Garcia-Manero, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Jianqin Shan, Jorge Cortes

Journal:

Year:

2012

Language:

english

File:

PDF, 486 KB

english, 2012

68

Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients

Stefan Faderl, Farhad Ravandi, Xuelin Huang, Xuemei Wang, Elias Jabbour, Guillermo Garcia-Manero, Tapan Kadia, Alessandra Ferrajoli, Marina Konopleva, Gautam Borthakur, Jan Burger, Jennie Feliu, Hagop

Journal:

Year:

2012

Language:

english

File:

PDF, 390 KB

english, 2012

69

Predicting survival of patients with hypocellular myelodysplastic syndrome : Development of a disease-specific prognostic score system

Wei-Gang Tong, Alfonso Quintás-Cardama, Tapan Kadia, Gautam Borthakur, Elias Jabbour, Farhad Ravandi, Stefan Faderl, William Wierda, Sherry Pierce, Jianqin Shan, Carlos Bueso-Ramos, Hagop Kantarjian,

Journal:

Year:

2012

Language:

english

File:

PDF, 447 KB

english, 2012

70

Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes

Tapan M. Kadia, Elias Jabbour, Hagop Kantarjian

Journal:

Seminars in Oncology

Year:

2011

Language:

english

File:

PDF, 762 KB

english, 2011

71

Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome

Tapan M. Kadia, Gautam Borthakur, Guillermo Garcia-Manero, Stefan Faderl, Elias Jabbour, Zeev Estrov, Sergerrne York, Xuelin Huang, Sherry Pierce, Mark Brandt, Charles Koller, Hagop M. Kantarjian, Far

Journal:

British Journal of Haematology

Year:

2012

Language:

english

File:

PDF, 184 KB

english, 2012

72

Current and Future Clinical Strategies in the Management of Chronic Myeloid Leukemia

Kamakshi V. Rao, Andrea Iannucci, Elias Jabbour

Journal:

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

Year:

2010

Language:

english

File:

PDF, 219 KB

english, 2010

73

The role of clofarabine in acute myeloid leukemia

Ghanem, Hady, Kantarjian, Hagop, Ohanian, Maro, Jabbour, Elias

Journal:

Leukemia and Lymphoma

Year:

2012

Language:

english

File:

PDF, 671 KB

english, 2012

74

Long-Term Follow-Up of Patients Who Experienced Graft Failure Postallogeneic Progenitor Cell Transplantation. Results of a Single Institution Analysis

Gabriela Rondón, Rima M. Saliba, Issa Khouri, Sergio Giralt, Kawah Chan, Elias Jabbour, John McMannis, Richard Champlin, Elizabeth Shpall

Journal:

Biology of Blood and Marrow Transplantation

Year:

2008

Language:

english

File:

PDF, 386 KB

english, 2008

75

Managing Side Effects of Tyrosine Kinase Inhibitor Therapy to Optimize Adherence in Patients with Chronic Myeloid Leukemia: The Role of the Midlevel Practitioner

Megan Cornelison, Elias J. Jabbour, Mary Alma Welch

Journal:

The Journal of Supportive Oncology

Year:

2012

Language:

english

File:

PDF, 374 KB

english, 2012

76

Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

Hagop Kantarjian, Deborah Thomas, Jeffrey Jorgensen, Elias Jabbour, Partow Kebriaei, Michael Rytting, Sergernne York, Farhad Ravandi, Monica Kwari, Stefan Faderl, Mary Beth Rios, Jorge Cortes, Luis Fa

Journal:

The Lancet Oncology

Year:

2012

Language:

english

File:

PDF, 255 KB

english, 2012

77

Introduction

Elias Jabbour, Hagop Kantarjian

Journal:

Seminars in Hematology

Year:

2007

Language:

english

File:

PDF, 81 KB

english, 2007

78

New Targeted Therapies for Chronic Myelogenous Leukemia: Opportunities to Overcome Imatinib Resistance

Elias Jabbour, Jorge Cortes, Susan O’Brien, Francis Giles, Hagop Kantarjian

Journal:

Seminars in Hematology

Year:

2007

Language:

english

File:

PDF, 128 KB

english, 2007

79

Thrombocytopenia in Patients With Myelodysplastic Syndromes

Jeffrey Bryan, Elias Jabbour, Hillary Prescott, Hagop Kantarjian

Journal:

Seminars in Hematology

Year:

2010

Language:

english

File:

PDF, 205 KB

english, 2010

80

Understanding the Role of Mutations in Therapeutic Decision Making for Chronic Myeloid Leukemia

Elias Jabbour, Simona Soverini

Journal:

Seminars in Hematology

Year:

2009

Language:

english

File:

PDF, 167 KB

english, 2009

81

Chronic Myeloid Leukemia and Second-Generation Tyrosine Kinase Inhibitors: When, How, and Which One?

Elias Jabbour, Hagop Kantarjian, Jorge Cortes

Journal:

Seminars in Hematology

Year:

2010

Language:

english

File:

PDF, 272 KB

english, 2010

82

Monitoring and switching patterns of patients with chronic myeloid leukemia treated with imatinib in community settings: a chart review analysis

Chen, Lei, Guérin, Annie, Xie, Jipan, Wu, Eric Q., Yu, Andrew P, Ericson, Solveig G., Jabbour, Elias

Journal:

Current Medical Research and Opinion

Year:

2012

Language:

english

File:

PDF, 299 KB

english, 2012

83

Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Mathisen, Michael S., Kantarjian, Hagop, Jabbour, Elias, Garcia-Manero, Guillermo, Ravandi, Farhad, Faderl, Stefan, Borthakur, Gautam, Cortes, Jorge E., Quintás-Cardama, Alfonso

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2013

Language:

english

File:

PDF, 304 KB

english, 2013

84

Chronic myeloid leukemia: 2012 update on diagnosis, monitoring, and management

Jabbour, Elias, Kantarjian, Hagop

Journal:

American Journal of Hematology

Year:

2012

Language:

english

File:

PDF, 134 KB

english, 2012

85

FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia

Daver, Naval, Strati, Paolo, Jabbour, Elias, Kadia, Tapan, Luthra, Raja, Wang, Sa, Patel, Keyur, Ravandi, Farhad, Cortes, Jorge, Qin Dong, Xiao, Kantarjian, Hagop, Garcia-Manero, Guillermo

Journal:

American Journal of Hematology

Year:

2013

Language:

english

File:

PDF, 152 KB

english, 2013

86

Advances in the biology and therapy of patients with chronic myeloid leukaemia

Elias Jabbour, Carmen Fava, Hagop Kantarjian

Journal:

Best Practice & Research Clinical Haematology

Year:

2009

Language:

english

File:

PDF, 174 KB

english, 2009

87

Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure

A. Megan Cornelison, Hagop Kantarjian, Jorge Cortes, Elias Jabbour

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 414 KB

english, 2011

88

Dasatinib Combined with Interferon-alfa Induces a Complete Cytogenetic Response and Major Molecular Response in a Patient with Chronic Myelogenous Leukemia Harboring the T315I BCR-ABL1 Mutation

A. Megan Cornelison, Mary-Alma Welch, Charles Koller, Elias Jabbour

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 390 KB

english, 2011

89

Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia Resistant to Tyrosine Kinase Inhibitors

Richard Champlin, Elias Jabbour, Partow Kebriaei, Paolo Anderlini, Borje Andersson, Marcos de Lima

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 270 KB

english, 2011

90

The Clinical Significance of Achieving Different Levels of Cytogenetic Response in Patients With Chronic Phase Chronic Myeloid Leukemia After Failure to Front-Line Therapy: Is Complete Cytogenetic Response the Only Desirable Endpoint?

Jorge Cortes, Alfonso Quintas-Cardama, Elias Jabbour, Susan O'Brien, Srdan Verstovsek, Gautam Borthakur, Farhad Ravandi, Guillermo Garcia-Manero, Elizabeth Burton, Jenny Shan, Hagop Kantarjian

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 222 KB

english, 2011

91

Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications

Ali Al Ameri, Elias Jabbour, Guillermo Garcia-Manero, Susan O'Brien, Stefan Faderl, Farhad Ravandi, Jianqin Shan, Sherry Pierce, Jorge Cortes, Hagop Kantarjian

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 1.09 MB

english, 2011

92

804 Dasatinib Combined with Interferon-α Achieves a Complete Cytogenetic Response (CCyR) and Major Molecular Response (MMR) in a Patient with Chronic Myelogenous Leukemia (CML) Harboring the T315I BCR-ABL1 Mutation

A. Megan Cornelison, Charles Koller, Elias Jabbour

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 184 KB

english, 2011

93

Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome

Christelle Chacar, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Tapan Kadia, Zeev Estrov, Mary Beth Rios, Jorge Cortes, Hagop Kantarjian

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2012

Language:

english

File:

PDF, 207 KB

english, 2012

94

Adherence to BCR-ABL Inhibitors: Issues for CML Therapy

Elias Jabbour, Giuseppe Saglio, Jerald Radich, Hagop Kantarjian

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2012

Language:

english

File:

PDF, 334 KB

english, 2012

95

Twice-Daily Fludarabine and Cytarabine Combination With or Without Gentuzumab Ozogamicin is Effective in Patients With Relapsed/Refractory Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, and Blast- Phase Chronic Myeloid Leukemia

Elias Jabbour, Guillermo Garcia-Manero, Jorge Cortes, Farhad Ravandi, William Plunkett, Varsha Gandhi, Stefan Faderl, Susan O'Brien, Gautam Borthakur, Tapan Kadia, Jan Burger, Marina Konopleva, Mark B

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2012

Language:

english

File:

PDF, 492 KB

english, 2012

96

Current and Future Management Options for Myelodysplastic Syndromes

Jeffrey Bryan, Dr Elias Jabbour, Hillary Prescott, Guillermo Garcia-Manero, Jean-Pierre Issa, Hagop Kantarjian

Journal:

Year:

2010

Language:

english

File:

PDF, 175 KB

english, 2010

97

Management of Patients with Newly Diagnosed Chronic Myeloid Leukemia: Opportunities and Challenges

Jabbour, Elias, Cortes, Jorge, O'Brien, Susan, Rios, Mary Beth, Giles, Francis, Kantarjian, Hagop

Journal:

Clinical Lymphoma & Myeloma

Year:

2007

Language:

english

File:

PDF, 134 KB

english, 2007

98

Optimizing Treatment with Bcr-Abl Tyrosine Kinase Inhibitors in Philadelphia Chromosome—Positive Chronic Myeloid Leukemia: Focus on Dosing Schedules

Jabbour, Elias, Cortés, Jorge E., Kantarjian, Hagop

Journal:

Clinical Lymphoma & Myeloma

Year:

2008

Language:

english

File:

PDF, 138 KB

english, 2008

99

Peripheral Blasts on Day 21 of Induction Chemotherapy in a Patient With Core Binding Factor Acute Myeloid Leukemia: More Than Meets the Eye

Sameer A. Parikh, Tapan Kadia, Elias Jabbour

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2010

Language:

english

File:

PDF, 85 KB

english, 2010

100

Nonmyeloablative Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia in the Imatinib Era

Champlin, Richard, de Lima, Marcos, Kebriaei, Partow, Rondon, Gabriela, Fisher, Tobi, Jabbour, Elias, Cortés, Jorge E., Kantarjian, Hagop, Anderlini, Paolo, Alousi, Amin, Hosing, Chitra, Shpall, Eliza

Journal:

Clinical Lymphoma & Myeloma

Year:

2009

Language:

english

File:

PDF, 154 KB

english, 2009